Gary K. Lee
Chief Scientific Officer at Lyell Immunopharma, Inc. (LYEL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $72K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 25SEC | LYELLyell Immunopharma, Inc. | Sell | 1,45716,220 held (−8%) | $15.54 | $23K | -44.0% |
| Aug 11SEC | LYELLyell Immunopharma, Inc. | Sell | 13117,677 held (−1%) | $14.34 | $2K | -39.3% |
| Jun 15SEC | LYELLyell Immunopharma, Inc. | Sell | 13017,808 held (−1%) | $18.92 | $2K | -54.0% |
| Feb 12SEC | LYELLyell Immunopharma, Inc. | Sell | 1,67116,938 held (−9%) | $23.39 | $39K | -62.8% |
| Feb 11SEC | LYELLyell Immunopharma, Inc. | Sell | 14718,609 held (−1%) | $23.12 | $3K | -62.3% |
| Nov 12SEC | LYELLyell Immunopharma, Inc. | Sell | 13815,366 held (−1%) | $16.16 | $2K | -46.1% |